Proteonomix Net Income

PROT Stock  USD 0.0001  0.00  0.00%   
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Proteonomix, as well as the relationship between them.

Proteonomix Total Revenue

22,233.42

Analyzing historical trends in various income statement and balance sheet accounts from Proteonomix's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Proteonomix's valuation are summarized below:
Gross Profit
26.5 K
Market Capitalization
791
Enterprise Value Revenue
6.4187
Revenue
26 K
Revenue Per Share
0.003
There are currently one hundred twenty trending fundamental ratios for Proteonomix that can be evaluated and compared over time across competitors. All traders should check out Proteonomix's recent fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 258 K in 2026. Enterprise Value is likely to drop to about 487.7 K in 2026 This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Loss-1.6 M-1.7 M
Net Loss-1.6 M-1.7 M
Net Loss-1.6 M-1.7 M
Net Loss(0.19)(0.20)
Net Income Per E B T 0.90  0.80 
Net Loss is likely to drop to about (1.7 M) in 2026. Net Loss is likely to drop to about (1.7 M) in 2026.
  
Build AI portfolio with Proteonomix Stock
The evolution of Net Income for Proteonomix provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Proteonomix compares to historical norms and industry peers.

Latest Proteonomix's Net Income Growth Pattern

Below is the plot of the Net Income of Proteonomix over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Proteonomix financial statement analysis. It represents the amount of money remaining after all of Proteonomix operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Proteonomix's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Proteonomix's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (1.38 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Proteonomix Net Income Regression Statistics

Arithmetic Mean(1,623,865)
Coefficient Of Variation(53.34)
Mean Deviation399,141
Median(1,383,846)
Standard Deviation866,121
Sample Variance750.2B
Range3.6M
R-Value0.36
Mean Square Error698.6B
R-Squared0.13
Significance0.16
Slope61,114
Total Sum of Squares12T

Proteonomix Net Income History

2026-1.7 M
2025-1.6 M
2011-1.4 M
2010-5 M

Other Fundumenentals of Proteonomix

Proteonomix Net Income component correlations

Proteonomix Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Proteonomix is extremely important. It helps to project a fair market value of Proteonomix Stock properly, considering its historical fundamentals such as Net Income. Since Proteonomix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Proteonomix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Proteonomix's interrelated accounts and indicators.
Is there potential for Biotechnology market expansion? Will Proteonomix introduce new products? Factors like these will boost the valuation of Proteonomix. Anticipated expansion of Proteonomix directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Proteonomix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.003
Return On Assets
(0.51)
Investors evaluate Proteonomix using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Proteonomix's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Proteonomix's market price to deviate significantly from intrinsic value.
It's important to distinguish between Proteonomix's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Proteonomix should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Proteonomix's market price signifies the transaction level at which participants voluntarily complete trades.

Proteonomix 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Proteonomix's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Proteonomix.
0.00
12/05/2025
No Change 0.00  0.0 
In 3 months and 1 day
03/05/2026
0.00
If you would invest  0.00  in Proteonomix on December 5, 2025 and sell it all today you would earn a total of 0.00 from holding Proteonomix or generate 0.0% return on investment in Proteonomix over 90 days. Proteonomix is related to or competes with Aprea Therapeutics, Adial Pharmaceuticals, Kiora Pharmaceuticals, Cardio Diagnostics, and Phio Pharmaceuticals. Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and the... More

Proteonomix Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Proteonomix's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Proteonomix upside and downside potential and time the market with a certain degree of confidence.

Proteonomix Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Proteonomix's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Proteonomix's standard deviation. In reality, there are many statistical measures that can use Proteonomix historical prices to predict the future Proteonomix's volatility.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

Proteonomix Backtested Returns

We have found three technical indicators for Proteonomix, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Proteonomix are completely uncorrelated.

Auto-correlation

    
  1.00  

Perfect predictability

Proteonomix has perfect predictability. Overlapping area represents the amount of predictability between Proteonomix time series from 5th of December 2025 to 19th of January 2026 and 19th of January 2026 to 5th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Proteonomix price movement. The serial correlation of 1.0 indicates that 100.0% of current Proteonomix price fluctuation can be explain by its past prices.
Correlation Coefficient1.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Proteonomix reported net income of (1.38 Million). This is 100.41% lower than that of the Biotechnology sector and 101.98% lower than that of the Health Care industry. The net income for all United States stocks is 100.24% higher than that of the company.

Proteonomix Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Proteonomix's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Proteonomix could also be used in its relative valuation, which is a method of valuing Proteonomix by comparing valuation metrics of similar companies.
Proteonomix is currently under evaluation in net income category among its peers.

Proteonomix Fundamentals

About Proteonomix Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Proteonomix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Proteonomix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Proteonomix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Proteonomix Stock Analysis

When running Proteonomix's price analysis, check to measure Proteonomix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Proteonomix is operating at the current time. Most of Proteonomix's value examination focuses on studying past and present price action to predict the probability of Proteonomix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Proteonomix's price. Additionally, you may evaluate how the addition of Proteonomix to your portfolios can decrease your overall portfolio volatility.